report adjust ep in-lin
estim consensu expect upper portion
compani guidanc rang consist januari
pre-announce rel forecast steeper declin adjust
oper margin higher net interest expens off-set
lower adjust tax rate quarter
syk revenu increas year-over-year million
consist compani pre-announce exclud acquisit
chang foreign currenc exchang rate syk sale improv
organ forecast
strong organ growth perform led neurotechnolog
organ instrument organ sustain solut
organ trauma extrem organ
knee organ includ unit state
syk adjust oper margin declin bp year-over-year
bp estim higher adjust sg
expens compani attribut impact recent acquisit
busi mix product suppli issu account
downsid versu adjust oper margin forecast notabl syk
adjust oper margin weaker initi anticip
bp year-over-year compani would achiev target
least bp adjust oper margin expans suppli
impact hurrican maria suppli issu product margin
dilut novadaq acquisit
expect adjust ep versu prior consensu
expect compani guidanc assum organ
growth bp adjust oper margin expans
adjust tax rate reflect impact tax reform
syk organ growth guidanc level
organ note compani exceed top end initi organ
growth guidanc past three year think trend
like continu
rais adjust ep estim
total debt total asset
deliv anoth quarter significantli better-than-expect organ
growth upsid consensu adjust ep estim margin
trend underwhelm think compani expect return
level consist long-term plan reason anniversari
suppli headwind relat product hurrican maria
realiz benefit transform growth program overal
remain posit long-term outlook maintain
buy rate new price target
import pleas read disclosur disclaim page report
report adjust ep in-lin estim consensu
expect upper portion compani guidanc rang consist januari
pre-announce rel forecast steeper declin adjust oper margin higher net interest
expens off-set lower adjust tax rate quarter
stryker adjust incom statement revenu analysisnorthcoast research million except percentag per share sg interest incom incom margin incom trauma sustain compani report northcoast research estim factset pre-announce revenu growth compani also indic adjust ep would upper portion guidanc rang revenu increas year-over-year million consist compani
pre-announce exclud acquisit chang foreign currenc exchang rate syk sale
improv organ forecast compani pre-announce
similar strong result syk medsurg equip busi drove upsid rel
organ growth forecast compani pre-announce addit neurotechnolog spine
product also deliv best perform year exceed estim favor orthoped
result similar outlook
medsurg equip achiev organ growth forecast
compani pre-announce quarter medic organ growth particularli strong
versu neg estim compani pre-announce expect sale headwind
product suppli issu bad initi anticip million versu compani
neg million guidanc addit sale core medic product stretcher hospit bed
physio-control except strong high-teen year-over-year second straight quarter syk
instrument busi also post best result year organ led power
surgic instrument launch favor trend sustain solut organ endoscopi
roughli exclud novadaq acquisit continu
stryker corporationtot compani organ growth analysi two fewer sale day year-over-year one extra sale day year-over-year one fewer sale day year-over-year compani report corpor organ growth analysiscategorynorthcoastreportedtot compani organ orthoped medsurg equip neurotechnolog spine compani report northcoast research estim
orthoped product syk sale increas organ similar estim
compani pre-announce quarter trauma extrem organ growth
better anticip led low-double-digit growth addit sale compani hip knee
product similar estim market growth improv sequenti syk market share gain
acceler contrast organ growth orthoped product weaker anticip
organ tough comparison mako unit sale reach compani
continu focu custom upgrad mako total knee applic proceed faster
expect quarter
knee implant achiev organ growth meaning year-over-
year increas compani benefit stronger market trend increas market share gain
quarter syk knee implant organ growth particularli strong unit state year-over-
slightli forecast compani pre-announce compani
experienc increas demand cementless triathlon tritanium knee system domest total knee
implant busi exit addit mako system sale competit account increas surgeon
train mako total knee implant applic versu roughli syk earn call
total case perform syk mako total knee applic follow gener launch
march includ roughli moreov suggest roughli mako total knee
applic case perform surgeon previous primarili use knee implant anoth
hip implant achiev organ growth forecast
compani pre-announce modestli ahead market rate similar knee benefit improv
 market condit help compani achiev strongest hip perform year overal
encourag syk hip result particularli given focu key differenti knee mako total knee
applic cementless knee offer within orthoped divis year
neurotechnolog spine product achiev organ growth
forecast compani pre-announce similar recent quarter neurotechnolog sale
except strong organ led ischem stroke busi meaning contribut
hemorrhag stroke neuro power instrument cmf product categori well contrast syk
spine organ growth remain letharg organ reflect difficult market condit particularli
unit state
syk adjust oper margin declin bp year-over-year bp
estim higher adjust sg expens compani attribut impact recent acquisit
busi mix product suppli issu account downsid versu adjust oper
margin forecast addit expans adjust gross margin modest bp compani
continu impact recoveri puerto rico manufactur facil dilut acquisit
neg price year-over-year similar full-year trend notabl syk adjust oper
margin weaker initi anticip bp year-over-year compani would
achiev target least bp adjust oper margin expans suppli impact
hurrican maria suppli issu product margin dilut novadaq acquisit
expect adjust ep versu prior consensu expect compani
guidanc assum organ growth bp adjust oper margin expans
adjust tax rate reflect impact tax reform syk organ growth guidanc
stryker corporationneurotechnolog spine organ growth analysi compani report two fewer sale day year-over-year one extra sale day year-over-year one fewer sale day corporationtot compani price growth year-over-year compani report level organ note compani exceed top end initi
organ growth guidanc past three year think trend like continu
rais adjust ep estim primarili reflect modestli higher revenu
margin assumpt
overal deliv anoth quarter significantli better-than-expect organ growth upsid
consensu adjust ep estim margin trend underwhelm think compani
expect return level consist long-term plan reason anniversari suppli
headwind relat product hurrican maria realiz benefit
transform growth program overal remain posit long-term outlook
maintain buy rate new price target
stryker corporationannu incom statement analysi adjust northcoast research million except percentag per share gross gross sg intang stock option expensesn/an/an/an/an/an/an/a oper oper net interest incom interest incom incom tax incom extra incom extra extra net net wghd com share ep ep growth ep growth start exclud acquistion-rel intang amort expens adjust ep compani report northcoast research estim disclosur
